Sickle Cell Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Sickle Cell Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sickle Cell Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sickle Cell Treatment Overall Market Size
2.1 Global Sickle Cell Treatment Market Size: 2021 VS 2028
2.2 Global Sickle Cell Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sickle Cell Treatment Players in Global Market
3.2 Top Global Sickle Cell Treatment Companies Ranked by Revenue
3.3 Global Sickle Cell Treatment Revenue by Companies
3.4 Top 3 and Top 5 Sickle Cell Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sickle Cell Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sickle Cell Treatment Players in Global Market
3.6.1 List of Global Tier 1 Sickle Cell Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Sickle Cell Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Sickle Cell Treatment Market Size Markets, 2021 & 2028
4.1.2 Blood Transfusion
4.1.3 Bone Marrow Transplant
4.1.4 Pharmacotherapy
4.2 By Type - Global Sickle Cell Treatment Revenue & Forecasts
4.2.1 By Type - Global Sickle Cell Treatment Revenue, 2017-2022
4.2.2 By Type - Global Sickle Cell Treatment Revenue, 2023-2028
4.2.3 By Type - Global Sickle Cell Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sickle Cell Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Sickle Cell Treatment Revenue & Forecasts
5.2.1 By Application - Global Sickle Cell Treatment Revenue, 2017-2022
5.2.2 By Application - Global Sickle Cell Treatment Revenue, 2023-2028
5.2.3 By Application - Global Sickle Cell Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Sickle Cell Treatment Market Size, 2021 & 2028
6.2 By Region - Global Sickle Cell Treatment Revenue & Forecasts
6.2.1 By Region - Global Sickle Cell Treatment Revenue, 2017-2022
6.2.2 By Region - Global Sickle Cell Treatment Revenue, 2023-2028
6.2.3 By Region - Global Sickle Cell Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Sickle Cell Treatment Revenue, 2017-2028
6.3.2 US Sickle Cell Treatment Market Size, 2017-2028
6.3.3 Canada Sickle Cell Treatment Market Size, 2017-2028
6.3.4 Mexico Sickle Cell Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Sickle Cell Treatment Revenue, 2017-2028
6.4.2 Germany Sickle Cell Treatment Market Size, 2017-2028
6.4.3 France Sickle Cell Treatment Market Size, 2017-2028
6.4.4 U.K. Sickle Cell Treatment Market Size, 2017-2028
6.4.5 Italy Sickle Cell Treatment Market Size, 2017-2028
6.4.6 Russia Sickle Cell Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Sickle Cell Treatment Market Size, 2017-2028
6.4.8 Benelux Sickle Cell Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Sickle Cell Treatment Revenue, 2017-2028
6.5.2 China Sickle Cell Treatment Market Size, 2017-2028
6.5.3 Japan Sickle Cell Treatment Market Size, 2017-2028
6.5.4 South Korea Sickle Cell Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Sickle Cell Treatment Market Size, 2017-2028
6.5.6 India Sickle Cell Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Sickle Cell Treatment Revenue, 2017-2028
6.6.2 Brazil Sickle Cell Treatment Market Size, 2017-2028
6.6.3 Argentina Sickle Cell Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sickle Cell Treatment Revenue, 2017-2028
6.7.2 Turkey Sickle Cell Treatment Market Size, 2017-2028
6.7.3 Israel Sickle Cell Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Sickle Cell Treatment Market Size, 2017-2028
6.7.5 UAE Sickle Cell Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Sickle Cell Treatment Major Product Offerings
7.1.4 Novartis AG Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.1.5 Novartis AG Key News
7.2 Global Blood Therapeutics Inc.
7.2.1 Global Blood Therapeutics Inc. Corporate Summary
7.2.2 Global Blood Therapeutics Inc. Business Overview
7.2.3 Global Blood Therapeutics Inc. Sickle Cell Treatment Major Product Offerings
7.2.4 Global Blood Therapeutics Inc. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.2.5 Global Blood Therapeutics Inc. Key News
7.3 EMI Holding, Inc.
7.3.1 EMI Holding, Inc. Corporate Summary
7.3.2 EMI Holding, Inc. Business Overview
7.3.3 EMI Holding, Inc. Sickle Cell Treatment Major Product Offerings
7.3.4 EMI Holding, Inc. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.3.5 EMI Holding, Inc. Key News
7.4 Addmedica Inc.
7.4.1 Addmedica Inc. Corporate Summary
7.4.2 Addmedica Inc. Business Overview
7.4.3 Addmedica Inc. Sickle Cell Treatment Major Product Offerings
7.4.4 Addmedica Inc. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.4.5 Addmedica Inc. Key News
7.5 Medunik USA.Inc.
7.5.1 Medunik USA.Inc. Corporate Summary
7.5.2 Medunik USA.Inc. Business Overview
7.5.3 Medunik USA.Inc. Sickle Cell Treatment Major Product Offerings
7.5.4 Medunik USA.Inc. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.5.5 Medunik USA.Inc. Key News
7.6 Bristol Myers Squibb Co.
7.6.1 Bristol Myers Squibb Co. Corporate Summary
7.6.2 Bristol Myers Squibb Co. Business Overview
7.6.3 Bristol Myers Squibb Co. Sickle Cell Treatment Major Product Offerings
7.6.4 Bristol Myers Squibb Co. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.6.5 Bristol Myers Squibb Co. Key News
7.7 Baxter Inc.
7.7.1 Baxter Inc. Corporate Summary
7.7.2 Baxter Inc. Business Overview
7.7.3 Baxter Inc. Sickle Cell Treatment Major Product Offerings
7.7.4 Baxter Inc. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.7.5 Baxter Inc. Key News
7.8 Bluebird Biotechnology
7.8.1 Bluebird Biotechnology Corporate Summary
7.8.2 Bluebird Biotechnology Business Overview
7.8.3 Bluebird Biotechnology Sickle Cell Treatment Major Product Offerings
7.8.4 Bluebird Biotechnology Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.8.5 Bluebird Biotechnology Key News
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Corporate Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. Sickle Cell Treatment Major Product Offerings
7.9.4 Pfizer Inc. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.9.5 Pfizer Inc. Key News
7.10 Eli-Lilly and Co.
7.10.1 Eli-Lilly and Co. Corporate Summary
7.10.2 Eli-Lilly and Co. Business Overview
7.10.3 Eli-Lilly and Co. Sickle Cell Treatment Major Product Offerings
7.10.4 Eli-Lilly and Co. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.10.5 Eli-Lilly and Co. Key News
7.11 Glycomimetics Inc.
7.11.1 Glycomimetics Inc. Corporate Summary
7.11.2 Glycomimetics Inc. Business Overview
7.11.3 Glycomimetics Inc. Sickle Cell Treatment Major Product Offerings
7.11.4 Glycomimetics Inc. Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.11.5 Glycomimetics Inc. Key News
7.12 F.Hoffmann-La Roche
7.12.1 F.Hoffmann-La Roche Corporate Summary
7.12.2 F.Hoffmann-La Roche Business Overview
7.12.3 F.Hoffmann-La Roche Sickle Cell Treatment Major Product Offerings
7.12.4 F.Hoffmann-La Roche Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.12.5 F.Hoffmann-La Roche Key News
7.13 CRISPR Therapeutics
7.13.1 CRISPR Therapeutics Corporate Summary
7.13.2 CRISPR Therapeutics Business Overview
7.13.3 CRISPR Therapeutics Sickle Cell Treatment Major Product Offerings
7.13.4 CRISPR Therapeutics Sickle Cell Treatment Revenue in Global Market (2017-2022)
7.13.5 CRISPR Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Sickle Cell Treatment Market Opportunities & Trends in Global Market
Table 2. Sickle Cell Treatment Market Drivers in Global Market
Table 3. Sickle Cell Treatment Market Restraints in Global Market
Table 4. Key Players of Sickle Cell Treatment in Global Market
Table 5. Top Sickle Cell Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sickle Cell Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sickle Cell Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sickle Cell Treatment Product Type
Table 9. List of Global Tier 1 Sickle Cell Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sickle Cell Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Sickle Cell Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sickle Cell Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sickle Cell Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Sickle Cell Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sickle Cell Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sickle Cell Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Sickle Cell Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sickle Cell Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sickle Cell Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sickle Cell Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sickle Cell Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sickle Cell Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sickle Cell Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sickle Cell Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sickle Cell Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sickle Cell Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sickle Cell Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sickle Cell Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sickle Cell Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Sickle Cell Treatment Product Offerings
Table 32. Novartis AG Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Global Blood Therapeutics Inc. Corporate Summary
Table 34. Global Blood Therapeutics Inc. Sickle Cell Treatment Product Offerings
Table 35. Global Blood Therapeutics Inc. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 36. EMI Holding, Inc. Corporate Summary
Table 37. EMI Holding, Inc. Sickle Cell Treatment Product Offerings
Table 38. EMI Holding, Inc. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Addmedica Inc. Corporate Summary
Table 40. Addmedica Inc. Sickle Cell Treatment Product Offerings
Table 41. Addmedica Inc. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Medunik USA.Inc. Corporate Summary
Table 43. Medunik USA.Inc. Sickle Cell Treatment Product Offerings
Table 44. Medunik USA.Inc. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bristol Myers Squibb Co. Corporate Summary
Table 46. Bristol Myers Squibb Co. Sickle Cell Treatment Product Offerings
Table 47. Bristol Myers Squibb Co. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Baxter Inc. Corporate Summary
Table 49. Baxter Inc. Sickle Cell Treatment Product Offerings
Table 50. Baxter Inc. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Bluebird Biotechnology Corporate Summary
Table 52. Bluebird Biotechnology Sickle Cell Treatment Product Offerings
Table 53. Bluebird Biotechnology Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Inc. Corporate Summary
Table 55. Pfizer Inc. Sickle Cell Treatment Product Offerings
Table 56. Pfizer Inc. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Eli-Lilly and Co. Corporate Summary
Table 58. Eli-Lilly and Co. Sickle Cell Treatment Product Offerings
Table 59. Eli-Lilly and Co. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Glycomimetics Inc. Corporate Summary
Table 61. Glycomimetics Inc. Sickle Cell Treatment Product Offerings
Table 62. Glycomimetics Inc. Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 63. F.Hoffmann-La Roche Corporate Summary
Table 64. F.Hoffmann-La Roche Sickle Cell Treatment Product Offerings
Table 65. F.Hoffmann-La Roche Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
Table 66. CRISPR Therapeutics Corporate Summary
Table 67. CRISPR Therapeutics Sickle Cell Treatment Product Offerings
Table 68. CRISPR Therapeutics Sickle Cell Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Sickle Cell Treatment Segment by Type in 2021
Figure 2. Sickle Cell Treatment Segment by Application in 2021
Figure 3. Global Sickle Cell Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sickle Cell Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sickle Cell Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sickle Cell Treatment Revenue in 2021
Figure 8. By Type - Global Sickle Cell Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sickle Cell Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sickle Cell Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sickle Cell Treatment Revenue Market Share, 2017-2028
Figure 12. US Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sickle Cell Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sickle Cell Treatment Revenue Market Share, 2017-2028
Figure 24. China Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sickle Cell Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sickle Cell Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sickle Cell Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Global Blood Therapeutics Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. EMI Holding, Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Addmedica Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medunik USA.Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol Myers Squibb Co. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Baxter Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bluebird Biotechnology Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli-Lilly and Co. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Glycomimetics Inc. Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. F.Hoffmann-La Roche Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. CRISPR Therapeutics Sickle Cell Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
